肥胖合并腹部手术后低氧性呼吸衰竭患者再插管:无创通气随机临床试验的事后分析
本文为多中心随机对照试验的事后分析,纳入腹部手术后7天内发生急性低氧性呼吸衰竭的肥胖患者76例(占全部293例的26%),比较经面罩无创通气与标准氧疗。主要终点7天内再插管率无创通气组13/42(31%)显著低于标准氧疗组19/34(56%),绝对差-25%(95%CI -49至-1%,p=0.03);无创通气组无创通气天数更多(27.1±8.6 vs 22.7±11.1天,p=0.02),ICU获得性肺炎更少(1/42,2% vs 6/34,18%,p=0.04);30天生存率98%(41/42)vs 85%(p=0.08)。BMI<30 kg/m²亚组中无创通气36/105(34%)与标准氧疗47/109(43%)差异无统计学意义(p=0.03),交互检验未发现肥胖与否的统计学显著差异。作者认为,肥胖患者使用无创通气可降低再插管风险,与非肥胖患者相反,但交互检验无显著差异,可能为亚组把握度不足或整体差异由肥胖亚组较大效应驱动。
要点
- 肥胖合并腹部手术后低氧性呼吸衰竭患者,无创通气组7天内再插管13/42(31%)显著低于标准氧疗组19/34(56%),绝对差-25%(95%CI -49至-1%,p=0.03)。
- 无创通气组无创通气天数显著多于标准氧疗组(27.1±8.6 vs 22.7±11.1天,p=0.02)。
- ICU获得性肺炎无创通气组1/42(2%)显著少于标准氧疗组6/34(18%)(p=0.04)。
- 30天生存率无创通气组98%(41/42)vs 标准氧疗组85%(p=0.08),差异未达统计学显著。
- BMI<30 kg/m²患者中无创通气36/105(34%)vs 标准氧疗47/109(43%)(p=0.03),交互检验未发现肥胖与否的统计学显著差异。
适用人群与场景
- 肥胖(BMI≥30 kg/m²)且腹部手术后7天内发生急性低氧性呼吸衰竭的患者,纳入意向性治疗分析。
- 非肥胖(BMI<30 kg/m²)腹部手术后低氧性呼吸衰竭患者作为对照亚组分析。
诊断标准与关键阈值
- 肥胖定义为BMI≥30 kg/m²;非肥胖为BMI<30 kg/m²。
- 急性低氧性呼吸衰竭发生于腹部手术后7天内。
处置流程与药物剂量
- 无创通气经面罩给予,对照为标准氧疗;原文未报告具体通气参数、氧流量或治疗疗程。
研究设计与关键结果
- 研究类型:多中心随机对照试验的事后分析;样本量:293例腹部手术后低氧性呼吸衰竭患者中76例(26%)肥胖患者纳入意向性治疗分析。
- 主要终点7天内再插管率:无创通气组13/42(31%)vs 标准氧疗组19/34(56%),绝对差-25%(95%CI -49至-1%,p=0.03)。
- 次要终点无创通气天数:无创通气组27.1±8.6天 vs 标准氧疗组22.7±11.1天(p=0.02)。
- 次要终点ICU获得性肺炎:无创通气组1/42(2%)vs 标准氧疗组6/34(18%)(p=0.04)。
- 次要终点30天生存率:无创通气组98%(41/42)vs 标准氧疗组85%(p=0.08)。
- BMI<30 kg/m²亚组:无创通气组36/105(34%)vs 标准氧疗组47/109(43%)(p=0.03),差异无统计学意义。
- 交互检验:BMI≥30 kg/m²与BMI<30 kg/m²两亚组间无统计学显著差异。
证据类型、等级与局限
- 证据类型:多中心随机对照试验的事后分析。
- 局限:事后分析;肥胖亚组样本量小(76例);交互检验未发现统计学显著差异,作者认为可能为亚组把握度不足,或整体样本的统计学差异由肥胖亚组的较大效应驱动。
对床旁实践的改变
- 在肥胖合并腹部手术后低氧性呼吸衰竭患者中,无创通气较标准氧疗降低了7天内再插管率及ICU获得性肺炎发生率,并增加了无创通气天数;但原文为事后分析,未据此给出推荐。
- 对非肥胖(BMI<30 kg/m²)患者,无创通气与标准氧疗再插管率差异无统计学意义,原文交互检验未发现肥胖与否的显著交互作用。
指南或共识出处
- Intensive Care Med发表的多中心随机对照试验的事后分析
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Although noninvasive ventilation (NIV) may reduce reintubation in patients with acute hypoxemic respiratory failure following abdominal surgery, this strategy has not been specifically assessed in patients with obesity.
METHODS: We conducted a post hoc analysis of a multicenter randomized controlled trial comparing NIV delivered via facial mask to standard oxygen therapy among patients with obesity and acute hypoxemic respiratory failure within 7 days after abdominal surgery. The primary outcome was reintubation within 7 days. Secondary outcomes were invasive ventilation-free days at day 30, intensive care unit (ICU)-acquired pneumonia and 30-day survival.
RESULTS: Among 293 patients with hypoxemic respiratory failure following abdominal surgery, 76 (26%) patients had obesity and were included in the intention-to-treat analysis. Reintubation rate was significantly lower with NIV (13/42, 31%) than with standard oxygen therapy (19/34, 56%) within 7 days (absolute difference: - 25%, 95% confidence interval (CI) - 49 to - 1%, p = 0.03). NIV was associated with significantly more invasive ventilation-free days compared with standard oxygen therapy (27.1 ± 8.6 vs 22.7 ± 11.1 days; p = 0.02), while fewer patients developed ICU-acquired pneumonia (1/42, 2% vs 6/34, 18%; p = 0.04). The 30-day survival was 98% in the NIV group (41/42) versus 85% in the standard oxygen therapy (p = 0.08). In patients with body mass index (BMI) < 30 kg/m2, no significant difference was observed between NIV (36/105, 34%) and standard oxygen therapy (47/109, 43%, p = 0.03). An interaction test showed no statistically significant difference between the two subsets (BMI ≥ 30 kg/m2 and BMI < 30 kg/m2).
CONCLUSIONS: Among patients with obesity and hypoxemic respiratory failure following abdominal surgery, use of NIV compared with standard oxygen therapy reduced the risk of reintubation within 7 days, contrary to patients without obesity. However, no interaction was found according to the presence of obesity or not, suggesting either a lack of power to conclude in the non-obese subgroup despite existing differences, or that the statistical difference found in the overall sample was driven by a large effect in the obese subsets.
参考来源
- Jaber S, Pensier J, Futier E, et al. Noninvasive ventilation on reintubation in patients with obesity and hypoxemic respiratory failure following abdominal surgery: a post hoc analysis of a randomized clinical trial. Intensive Care Med. 2024. PMID: 39073580. doi:10.1007/s00134-024-07522-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。